MicroRNA Study Yields Potential Marker for Oligometastases Treatment Success | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The expression of microRNAs in the miR-200 family is elevated in oligometastases cases that fail to respond to aggressive treatment, according to a study appearing online last night in PLoS ONE, suggesting miRNA markers may help guide treatment for individuals with this type of metastasis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.